Uncategorized
Exploring California’s cannabis supply chain
Cannabis Wealth speaks to Rob Koch, director of strategy and information at California distributor, Nabis.
Stephanie Price
March 10, 2022
Cannabis Wealth speaks to Rob Koch, director of strategy and information at California distributor, Nabis.
The CBX Stock Exchange will offer “seed to shelf” transparency.
Oxford Cannabinoid Technologies has stated it will begin Phase I clinical trials early next year.
The company stated it reached a significant milestone last year.
THC beverages are growing in popularity driven by a shift away from alcohol.
Patients will now be able to access Kanabo’s medical cannabis and CBD products through The GP Service (GPS).
The UK-based CBD brand will out the funds towards streamlining the business.
Canxchange explores how a lack of coherent price indexing for hemp affects the commodity’s prices.
The legalisation of cannabis has been a boon for the financial industry, says new study.
New Frontier Data has released its latest industry report exploring predictions for the year to come.
A new report has projected the market to exceed $310m by 2027.
Canxchange is introducing more transparency, liquidity and efficiency to the growing cannabis market through its new platform.
The company has announced a new parent name and a profitable second fiscal quarter, with ongoing progress across the EU.
The new Research and Markets report estimates the market will grow at a CAGR of 19.6 per cent.
2021 has been a good year for the cannabis industry, says the new Brightfield Group report.
Research and Markets has projected the global hemp derivatives market to grow at a CAGR of 19.7 per cent from 2021 to 2028.
The global cannabinoid pharmaceuticals market has been projected to reach £1.53bn (€1.8bn).
Fortune Business Insights says the market will grow at a CAGR of 50.9 per cent from 2020 to 2027.
We won’t spam you